Who owns Harmony Biosciences Holdings, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HRMY from SEC Form 13F filings across 327 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 327 institutions disclosed 54.2M shares of Harmony Biosciences Holdings, Inc. worth $1.97B — about 93.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
327
13F holders
$1.97B
value, 2026 filers
93.5%
of shares outstanding (54.2M sh)
56
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of HRMY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.1M | $258.6M | 0.0% | 12.3% | +0.5% |
| 2 | FMR LLC | 3.6M | $130.1M | 0.0% | 6.2% | +13.2% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | $104.9M | 0.0% | 5% | +6.1% |
| 4 | AMERICAN CENTURY COMPANIES INC | 2.5M | $92.5M | 0.0% | 4.4% | +20.6% |
| 5 | DIMENSIONAL FUND ADVISORS LP | 2.4M | $87.1M | 0.0% | 4.1% | +15.3% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $76.6M | 0.0% | 3.6% | +0.1% |
| 7 | LSV ASSET MANAGEMENT | 2.1M | $75.0M | 0.1% | 3.6% | +1.8% |
| 8 | STATE STREET CORP | 1.9M | $67.7M | 0.0% | 3.2% | +4.2% |
| 9 | ARMISTICE CAPITAL, LLC | 1.6M | $56.9M | 0.7% | 2.7% | -3.7% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $52.5M | 0.0% | 2.5% | +9.1% |
| 11 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.3M | $47.8M | 0.0% | 2.3% | -5.0% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1.2M | $43.5M | 0.1% | 2.1% | +11.0% |
| 13 | TWO SIGMA INVESTMENTS, LP | 959,136 | $34.9M | 0.0% | 1.7% | +30.8% |
| 14 | AQR CAPITAL MANAGEMENT LLC | 934,326 | $34.0M | 0.0% | 1.6% | +30.4% |
| 15 | SG Americas Securities, LLC | 882,720 | $32.1M | 0.0% | 1.5% | -56.3% |
| 16 | Valor Management LLC | 818,013 | $29.8M | 0.0% | 1.4% | +598.4% |
| 17 | MORGAN STANLEY | 733,684 | $26.7M | 0.0% | 1.3% | -28.8% |
| 18 | UBS Group AG | 602,990 | $22.0M | 0.0% | 1% | +34.6% |
| 19 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 551,075 | $20.1M | 0.0% | 1% | -2.8% |
| 20 | Invesco Ltd. | 528,520 | $19.2M | 0.0% | 0.9% | -15.9% |
| 21 | JPMORGAN CHASE & CO | 514,085 | $18.2M | 0.0% | 0.9% | -37.6% |
| 22 | venBio Partners LLC | 472,194 | $17.2M | 3.3% | 0.8% | -3.5% |
| 23 | NORTHERN TRUST CORP | 471,221 | $17.2M | 0.0% | 0.8% | +11.3% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 438,302 | $16.0M | 0.0% | 0.8% | -19.6% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 423,824 | $15.4M | 0.0% | 0.7% | +3.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.